Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services

Gene

Volumn 535, Issue 1, 2014, Pages 70-78

  Roberts, Jennifer L ^a   Hovanes, Karine ^b   Dasouki, Majed ^c,d   Manzardo, Ann M ^a   Butler, Merlin G ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b CombiMatrix Diagnostics ^*  (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Autism spectrum disorders (ASD); Chromosomal microarray analysis; Copy number variant (CNV); Developmental delay; Learning disability

Indexed keywords

ADULT; ARTICLE; AUTISM; CHILD; CHROMOSOME 15; CHROMOSOME 2; CHROMOSOME 22; CHROMOSOME DUPLICATION; COPY NUMBER VARIATION; FEMALE; GENDER; GENETIC SERVICE; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MICROCEPHALY; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE;

EID: 84890139081     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.10.020     Document Type: Article

References (84)

1. Abou J.R., et al. Genetic variation of the FAT gene at 4q35 is associated with bipolar affective disorder. Mol. Psychiatry 2008, 13:277-284.
2. Aggarwal S., Bogula V.R., Mandal K., Kumar R., Phadke S.R. Aetiologic spectrum of mental retardation & developmental delay in India. Indian J. Med. Res. 2012, 136:436-444.
3. Akawi N.A., Al-Jasmi F., Al-Shamsi A.M., Ali B.R., Al-Gazali L. LINS, a modulator of the WNT signaling pathway, is involved in human cognition. Orphanet J. Rare Dis. 2013, 8:87.
4. Alberti C.R., et al. 1.5Mb de novo 22q11.21 microduplication in a patient with cognitive deficits and dysmorphic facial features. Clin. Genet. 2007, 71:177-182.
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association Press, Washington D.C. 4 ed.
6. Autism, Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill. Summ. 2012, 61:1-19.
7. Bachmann-Gagescu R., et al. Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity. Genet. Med. 2010, 12:641-647.
8. Baris H., et al. Identification of a novel polymorphism-the duplication of the NPHP1 (nephronophthisis 1) gene. Am. J. Med. Genet. A 2006, 140A:1876-1879.
9. Battaglia A., et al. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. Eur. J. Paediatr. Neurol. 2013, (May 24, [Epub ahead of print]).
10. Behnecke A., et al. Intragenic deletions of IL1RAPL1: report of two cases and review of the literature. Am. J. Med. Genet. A 2011, 155A:372-379.
11. Bena F., et al. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature. Am. J. Med. Genet. B 2013, 162:388-403.
12. Bittel D.C., et al. Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH. Cytogenet. Genome Res. 2009, 124:113-120.
13. Brandau D.T., Lund M., Cooley L.D., Sanger W.G., Butler M.G. Autistic and dysmorphic features associated with a submicroscopic 2q33.3-q34 interstitial deletion detected by array comparative genomic hybridization. Am. J. Med. Genet. A 2008, 146A:521-524.
14. Breckpot J., et al. A novel genomic disorder: a deletion of the SACS gene leading to spastic ataxia of Charlevoix-Saguenay. Eur. J. Hum. Genet. 2008, 16:1050-1054.
15. Breitfeld J., Stumvoll M., Kovacs P. Genetics of adiponectin. Biochimie 2012, 94:2157-2163.
16. Bruno D.L., et al. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. J. Med. Genet. 2010, 47:299-311.
17. Burnside R.D., et al. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum. Genet. 2011, 130:517-528.
18. Butler M.G., Youngs E.L., Roberts J.L., Hellings J.A. Assessment and treatment in autism spectrum disorders: a focus on genetics and psychiatry. Autism Res. Treat. 2012, 2012:242537.
19. Capra V., et al. Identification of a rare 17p13.3 duplication including the BHLHA9 and YWHAE genes in a family with developmental delay and behavioural problems. BMC Med. Genet. 2012, 13:93.
20. Chien W.H., et al. Identification and molecular characterization of two novel chromosomal deletions associated with autism. Clin. Genet. 2012, 78:449-456.
21. Cross-Disorder Group of the Psychiatric Genomics Consortium Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379.
22. D'Angelo C.S., de Oliveira M.A., de Castro C.I., Koiffmann C.P. Molecular cytogenetic characterization of an inherited maternal duplication 20p11.21p13 associated with a small 20p11.21 deletion. Am. J. Med. Genet. A 2010, 152A:3197-3202.
23. Dasouki M.J., Lushington G.H., Hovanes K., Casey J., Gorre M. The 3q29 microdeletion syndrome: report of three new unrelated patients and in silico "RNA binding" analysis of the 3q29 region. Am. J. Med. Genet. A 2011, 155A:1654-1660.
24. De Ligt J., et al. Diagnostic exome sequencing in persons with severe intellectual disability. New Engl. J. Med. 2012, 367:1921-1929.
25. Devlin B., Scherer S.W. Genetic architecture in autism spectrum disorder. Curr. Opin. Genet. Dev. 2012, 22:229-237.
26. Dhar S.U., et al. 22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. Am. J. Med. Genet. A 2010, 152A:573-581.
27. Di Gregorio E., et al. Two Italian families with ITPR1 gene deletion presenting a broader phenotype of SCA15. Cerebellum 2010, 9:115-123.
28. Doco-Fenzy M., et al. The clinical spectrum associated with a chromosome 17 short arm proximal duplication (dup 17p11.2) in three patients. Am. J. Med. Genet. A 2008, 146:917-924.
29. El-Fishawy P., State M.W. The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr. Clin. North Am. 2010, 33:83-105.
30. Feyder M., et al. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Am. J. Psychiatry 2010, 167:1508-1517.
31. Flore L.A., Milunsky J.M. Updates in the genetic evaluation of the child with global developmental delay or intellectual disability. Semin. Pediatr. Neurol. 2012, 19:173-180.
32. Folstein S.E., Piven J. Etiology of autism: genetic influences. Pediatrics 1991, 87:767-773.
33. Franek K.J., et al. Deletion of the immunoglobulin domain of IL1RAPL1 results in nonsyndromic X-linked intellectual disability associated with behavioral problems and mild dysmorphism. Am. J. Med. Genet. A 2011, 155A:1109-1114.
34. Gedeon A.K., et al. The molecular basis of X-linked spondyloepiphyseal dysplasia tarda. Am. J. Hum. Genet. 2001, 68:1386-1397.
35. Griswold A.J., et al. Evaluation of copy number variations reveals novel candidate genes in autism spectrum disorder-associated pathways. Hum. Mol. Genet. 2012, 21:3513-3523.
36. Hattori A., et al. A novel mutation in the LMNA gene causes congenital muscular dystrophy with dropped head and brain involvement. Neuromuscul. Disord. 2012, 22:149-151.
37. Herman G.E., Henninger N., Ratliff-Schaub K., Pastore M., Fitzgerald S., McBride K.L. Genetic testing in autism: how much is enough?. Genet. Med. 2007, 9:268-274.
38. Individuals with Disabilities Education Improvement Act, 20 U.S.C. § 1400 et seq [Internet] Accessed 2013 April 11. Available from. http://idea.ed.gov/download/statute.html.
39. Kanner L. Autistic psychopathy in childhood. Nerv. Child. 1943, 2:217-250.
40. Kitsiou-Tzeli S., et al. Array-CGH analysis and clinical description of 2q37.3 de novo subtelomeric deletion. Eur. J. Med. Genet. 2007, 50:73-78.
41. Liu M.M., Zack D.J. Alternative splicing and retinal degeneration. Clin. Genet. 2013, 84:142-149.
42. Lu A.T., Dai X., Martinez-Agosto J.A., Cantor R.M. Support for calcium channel gene defects in autism spectrum disorders. Mol. Autism 2012, 3:18.
43. Manolakos E., et al. Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome). Mol. Cytogenet. 2009, 2:26.
44. Margarit E., et al. Familial 4.8MB deletion on 18q23 associated with growth hormone insufficiency and phenotypic variability. Am. J. Med. Genet. A 2012, 158A:611-616.
45. Mariani M., et al. Partial duplication of the PARK2 gene in a child with developmental delay and her normal mother: a second report. Am. J. Med. Genet. B 2013, 162B:485-486.
46. Martin C.L., et al. Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am. J. Med. Genet. B 2007, 144B:869-876.
47. Matsubara K., et al. Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency. Haematologica 2007, 92:e123-e1235.
48. Merla G., Brunetti-Pierri N., Micale L., Fusco C. Copy number variants at Williams-Beuren syndrome 7q11.23 region. Hum. Genet. 2010, 128:3-26.
49. Messinger D., et al. Beyond autism: a baby siblings research consortium study of high-risk children at three years of age. J. Am. Acad. Child Adolesc. Psychiatry 2013, 52:300-308.
50. Michelson D.J., Shevell M.I., Sherr E.H., Moeschler J.B., Gropman A.L., Ashwal S. Evidence report: genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2011, 77:1629-1635.
51. Miles J.H., Hillman R.E. Value of a clinical morphology examination in autism. Am. J. Med. Genet. 2000, 91:245-253.
52. Miller D.T., et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet. 2010, 86:749-764.
53. Nawara M., et al. Novel mutation of IL1RAPL1 gene in a nonspecific X-linked mental retardation (MRX) family. Am. J. Med. Genet. A. 2008, 146A:3167-3172.
54. Niemi A.K., Kwan A., Hudgins L., Cherry A.M., Manning M.A. Report of two patients and further characterization of interstitial 9p13 deletion-a rare but recurrent microdeletion syndrome?. Am. J. Med. Genet. A 2012, 158A:2328-2335.
55. Ozonoff S., et al. Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics 2011, 128:e488-e495.
56. Pescuccia C., et al. Chromosome 2 deletion encompassing the MAP2 gene in a patient with autism and Rett-like features. Clin. Genet. 2003, 64:497-501.
57. Petersen M.C., Kube D.A., Palmer F.B. Classification of developmental delays. Semin. Pediatr. Neurol. 1998, 5:2-14.
58. Pettem K.L., Yokomaku D., Takahashi H., Ge Y., Craig A.M. Interaction between autism-linked MDGAs and neuroligins suppresses inhibitory synapse development. J. Cell Biol. 2013, 200:321-336.
59. Philippe A., et al. Xq25 duplications encompassing GRIA3 and STAG2 genes in two families convey recognizable X-linked intellectual disability with distinctive facial appearance. Am. J. Med. Genet. A 2013, 161A:1370-1375.
60. Ramalingam A., et al. 16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders. J. Hum. Genet. 2011, 56:541-544.
61. Ren C.M., et al. Balanced translocation t(3;18)(p13;q22.3) and points mutation in the ZNF407 gene detected in patients with both moderate non-syndromic intellectual disability and autism. Biochim. Biophys. Acta 1832, 2013:431-438.
62. Sacharow S., Li D., Fan Y.S., Tekin M. Familial 16q24.3 microdeletion involving ANKRD11 causes a KBG-like syndrome. Am. J. Med. Genet. A 2012, 158A:547-552.
63. Sagar A., Bishop J.R., Tessman D.C., Guter S., Martin C.L., Cook E.H. Co-occurrence of autism, childhood psychosis, and intellectual disability associated with a de novo 3q29 microdeletion. Am. J. Med. Genet. A 2013, 161A:845-849.
64. Sanders S.R., et al. Interstitial deletion of chromosome 2p16.2p21. Clin. Dysmorphol. 2003, 12:183-185.
65. Scerri T.S., et al. The dyslexia candidate locus on 2p12 is associated with general cognitive ability and white matter structure. PLoS One 2012, 7:e50321.
66. Schaefer G.B., Lutz R.E. Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genet. Med. 2006, 8:549-556.
67. Schaefer G.B., Starr L., Pickering D., Skar G., Dehaai K., Sanger W.G. Array comparative genomic hybridization findings in a cohort referred for an autism evaluation. J. Child Neurol. 2010, 25:1498-1503.
68. Scheuerle A., Wilson K. PARK2 copy number aberrations in two children presenting with autism spectrum disorder: further support of an association and possible evidence for a new microdeletion/microduplication syndrome. Am. J. Med. Genet. B 2011, 156B:413-420.
69. Schluth-Bolard C., et al. 17p13.1 microdeletion involving the TP53 gene in a boy presenting with mental retardation but no tumor. Am. J. Med. Genet. A 2010, 152A:1278-1282.
70. Schroer R.J., et al. Autism and maternally derived aberrations of chromosome 15q. Am. J. Med. Genet. 1998, 76:327-336.
71. Shen Y., et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 2010, 125:e727-e735.
72. Shprintzen R.J. Velo-cardio-facial syndorme: 30years of study. Dev. Disabil. Res. Rev. 2008, 14:3-10.
73. Szafranski P., et al. Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological?. Hum. Mutat. 2010, 31:840-850.
74. Tentler D., et al. A candidate region for Asperger syndrome defined by two 17p breakpoints. Eur. J. Hum. Genet. 2003, 11:189-195.
75. Thomas N.S., et al. Clinical and molecular characterization of duplications encompassing the human SHOX gene reveal a variable effect on stature. Am. J. Med. Genet. A 2009, 149A:1407-1414.
76. Tsurusakia Y., et al. Coffin-Siris syndrome is a SWI/SNF complex disorder. Clin. Genet. 2013, (July 1, [Epub ahead of print]).
77. Uusimaa J., et al. Prospective study of POLG mutations presenting in children with intractable epilepsy: prevalence and clinical features. Epilepsia 2013, 54:1002-1011.
78. Vardarajan B.N., Eran A., Jung J.Y., Kunkel L.M., Wall D.P. Haplotype structure enables prioritization of common markers and candidate genes in autism spectrum disorder. Transl. Psychiatry 2013, 3:e262.
79. Weiss L.A., et al. Association between microdeletion and microduplication at 16p11.2 and autism. New Engl. J. Med. 2008, 358:667-775.
80. Williams S.R., et al. Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems. Am. J. Hum. Genet. 2010, 87:219-228.
81. Williams N.M., et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am. J. Psychiatry 2012, 169:195-204.
82. Youngs E.L., Henkhaus R.S., Hellings J.A., Butler M.G. 12-year-old boy with a 4q35.2 microdeletion and involvement of MTNR1A, FAT1, and F11 genes. Clin. Dysmorphol. 2012, 21:93-96.
83. Youngs E.L., Henkhaus R., Hellings J.A., Butler M.G. IL1RAPL1 gene deletion as a cause of X-linked intellectual disability and dysmorphic features. Eur. J. Med. Genet. 2012, 55:32-36.
84. Yu H.E., et al. A recurrent 1.71Mb genomic imbalance at 2q13 increases the risk of developmental delay and dysmorphism. Clin. Genet. 2012, 81:257-264.